News
01 Apr
Warwick spinout Cytoswim receives FDA clearance
Cytoswim has received clearance from the U.S. Food and Drug Administration (FDA) for its novel SpermAlign device which helps select high quality sperm for use in Assistive Reproductive Techniques.
10 Oct 2023
New Warwick spin-out company SEEV
Could e-voting be the future for general elections?
03 Oct 2023
Revolutionising AI for cellular pathology
Warwick spin-out Histofy to revolutionise AI for cellular pathology.
08 Sep 2023
Tools to solve global challenges
Equipping entrepreneurs and start-ups with the tools needed to solve global challenges.
26 Jul 2023
Synthetic biology platform
NanoSyrinx raises £6.2m to develop its synthetic biology platform for targeted intracellular engineering.
08 Jun 2023
Medherant to develop world’s only testosterone patch for menopause
Warwick spin out company Medherant to develop world’s only testosterone patch for menopause.